MAPT and Alzheimer disease: These findings complement recent immunohistochemical data documenting that 100% of 6-month-old 3xTg-AD females exhibit phospho-tau (Ser202/Thr205 and Ser422) in the hippocampus whereas male 3xTg-AD mice show considerable neuropathological variability [10].